Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy

about

Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy

Item

http://www.wikidata.org/entity/Q57929147

description

wetenschappelijk artikel

@nl

name

Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy

@en

Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy

@nl

type

Item

label

Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy

@en

Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy

@nl

prefLabel

Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy

@en

Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy

@nl

P1476

Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy

@en

P2093

Mamun Al-Mahtab

http://www.w3.org/2001/XMLSchema#string

Sakirul I Khan

http://www.w3.org/2001/XMLSchema#string

Sheikh Mf Akbar

http://www.w3.org/2001/XMLSchema#string

P2860

Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis

A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients.

Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy.

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.

Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

The global burden of liver disease: the major impact of China

Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients.

Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis.

Randomized controlled study investigating viral suppression and serological response following pre-S1/pre-S2/S vaccine therapy combined with lamivudine treatment in HBeAg-positive patients with chronic hepatitis B.

P304

42-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5005/JP-JOURNALS-10018-1256

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P698

29963460

http://www.w3.org/2001/XMLSchema#string

P932

6024052

http://www.w3.org/2001/XMLSchema#string